Contracts expiring soon — NAICS 541714 · Research and Development in Biotechnology (except Nanobiotechnology)
When a federal contract hits its end date, the agency usually buys the same thing again — and the rebid is open to anyone. These are the Research and Development in Biotechnology (except Nanobiotechnology) contracts coming up for renewal, soonest first.
529 contracts on the radar — page 6 of 11
THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A SECOND-GENERATION ASSAY FOR THE ORAQUICK EBOLA RAPID ANTIGEN TEST AS A SUSTAINABLE, ENHANCED TEST INCLUDING ALTERNATIVE REAGENTS (ANTIBODY AND ANTIGEN) WITH CONTINUED AVAILABILITY, EXTENDED SHELF-LIFE, A
INFINIUM GLOBAL DIVERSITY ARRAY-8 V1.0 KIT(96 SAMPLES) CAT#20031811 $7,892.10 (PLUS 1.5% SHIPPING) TOTAL: $24,031.45
RESEARCH PHYSIOLOGIST SUPPORT SERVICES
NIAAA: 1. 124 PAXGENE TUBES
COLORECTAL CANCER (CRC) PREVENTION BY UROLITHIN A IN RODENT CRC MODELS
CLONOSEQ TESTING FOR BOSTON AND WEST HAVEN VA HCS
FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASURE
NHGRI FOR SUPPLIES: 1. CATALOG 20087709: INF METHYLATIONEPIC V2.0 KIT (96 SPL). 2. CATALOG 20031811: INFINIUM GLOBAL DIVERSITY ARRAY-8 V1.0 KIT (96 SAMPLES). REFERENCE QUOTE 4811525.
BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES
RESEARCH
BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES
BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES
BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES
BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES
CARRRP TASK AREA A
IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES
THE DEFENSE HEALTH AGENCY DIRECTORATE REQUIRES SUPPORT TO ASSIST AND ENABLE THE DHA TO TRANSITION, IMPLEMENT AND SUSTAIN MATURE, PRIORITY, EVIDENCE BASED RESEARCH INTO PRACTICE TO OPTIMIZE ITS IMPACT.
NIAAA: 1. SERVICE FOR ITEM 86000: EXOSOMAL RNA SERVICE RNA PURIFICATION FROM INTACT EXOSOMES (ALIQUOT B) ELUTED INTO 2 ALIQUOTS OF RNA (1 VIAL TO BE RETURNED TO CLIENT) (1 VIAL FOR SMALL RNA-SEQ) QC OF RNA. 2. ITEM 85960: SMALL RNA-SEQUENCING LIBR
SCREENING CANDIDATE COUNTERMEASURES FOR VIRAL HEMORRHAGIC FEVER USING LIVER-BASED ORGAN-ON-A-CHIP MICROPHYSIOLOGICAL SYSTEMS (MPS) IN HIGH-LEVEL CONTAINMENT
SCREENING CANDIDATE COUNTERMEASURES FOR VIRAL ENCEPHALITIS IN HUMAN CENTRAL NERVOUS SYSTEM AND BLOOD BRAIN BARRIER (BBB) MICROPHYSIOLOGICAL SYSTEMS (MPS)
RUSH UNIVERSITY GENOMICS AND MICROBIOME CORE FACILITY RUSH UNIVERSITY MEDICAL CENTER:1107225 [26-005551]
NICHD: SERVICE: REPOSITORY SERVICES FOR DASH BIOBANK: SEVERABLE
MAIL MODERNIZATION PROJECT
REFINEMENT EDUCATION
RESEARCH ON REMODELING IN RENAL TUMOR PROGRESSION
PROTEIN EXPRESSION
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ASSESS THE ABILITY OF AURAVAX THERAPEUTICS? (AURAVAX) NOVEL MUCOSAL ADJUVANT NANOSTING-002, TOGETHER WITH INFLUENZA LIVE ATTENUATED VIRUS (LAV) CREATED WITH CODAGENIX NOVEL SYNTHETIC ATTENUATED VIRUS ENGIN
TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.
TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CONTRACEPTIVE CLINICAL TRIALS NETWORK ACTIVITIES.
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES. UNIVERSITY OF COLORADO-75N94020D00019/75N940
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES. 75N94020D00020/75N94020F00001
TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES. UNIVERSITY OF UTAH-75N94020D00021/75N94020F000
NICHD:R&D:DATA COORDINATING CENTER FOR PREPARATION, TRAINING ACTIVITIES, ENROLLMENT AND DATA COLLECTION AND DATA ANALYSIS OF THE SPAN STUDY:NON-SEVERABLE
THE PURPOSE OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II CONTRACT IS TO SHOW EFFICACY OF ANTI-VIRAL TREATMENT WITH THE PVX THERAPEUTIC.
DEVELOP A NEXT-GENERATION, MUCOSALLY DELIVERED, COVID-19 BOOSTER VACCINE CAPABLE OF ELICITING MUCOSAL IMMUNITY AND PROTECTING AGAINST SARS-COV-2 BREAKTHROUGH INFECTION AND TRANSMISSION
NEW WORLD SCREWWORM DETECTOR DOG TRAINING AID - NON-BIOLOGICAL. CREATE AND VALIDATE A SYNTHETIC SCENT THAT ACCURATELY REPRESENTS SCREWWORM LARVAE SO, DETECTION DOGS CAN IDENTIFY INFESTATIONS WITH GREATER PRECISION.
NIMH: SERVICE: SCIENTIFIC SUPPORT SERVICES: NON-SEVERABLE
MATERIALS MODIFICATION INC WP22-7521
TASK ORDER TITLE: PREVENTING LUNG ADENOCARCINOMA (LUAD) USING TRAIL INDUCING AGENT, ONC201 BASE CONTRACT TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS
INTESTINAL PERMEABILITY ASSESSMENT TESTING FOR R&D
COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)
See your codes' radar every morning.
Subscribers get this same radar filtered to their exact NAICS codes in the daily digest — plus every new open bid that matches. Start your 14-day trial →